Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for m root_references_citation in Reference Text / Citation (approximate match)

Showing 1031 - 1040 of 1135 results

First page
Previous page
Next page
Next page

MATRIX-M1 ADJUVANT

YZ7P8Y8ECX

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

AS04

C8385V1KQ6

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

LUCINACTANT

5BSH2G9BH8

Status:

US Previously Marketed

Source:

SURFAXIN by LEES PHARM HK

(2012)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021746

First approved in 2012

Source:

SURFAXIN by LEES PHARM HK

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021746

Class:

G1 SPECIFIED SUBSTANCE

SELECTIKINE

EI74F49ZLJ

Status:

Investigational

Source:

NCT00879866: Phase 1 Interventional Completed Lung Cancer

(2009)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00879866

Class:

CONCEPT

IMA-026

P52JII7PAL

Status:

Investigational

Source:

NCT00725582: Phase 1 Interventional Completed Asthma

(2008)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00725582

Class:

CONCEPT

AVID-100

91PZ0ZWR8S

Status:

Investigational

Source:

NCT03094169: Phase 1/Phase 2 Interventional Terminated Solid Tumor, Adult

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03094169

Class:

CONCEPT

MVT-5873

KEX1QY18OH

Status:

Investigational

Source:

NCT03801915: Phase 2 Interventional Completed Colon Cancer

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03801915

Class:

CONCEPT

MVT-1075

473BOU89F3

Status:

Investigational

Source:

NCT03118349: Phase 1 Interventional Terminated Pancreatic Carcinoma

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03118349

Class:

CONCEPT

MEMORY CYTOKINE-ENHANCED NK CELLS

637UW2W2GM

Status:

Other

Class:

CONCEPT

DVX-201

YU2RGF2APH

Status:

Other

Class:

CONCEPT

Concept

MATRIX-M1 ADJUVANT

Concept

AS04

Concept

LUCINACTANT

Concept

SELECTIKINE

Concept

IMA-026

Concept

AVID-100

Concept

MVT-5873

Concept

MVT-1075

Concept

MEMORY CYTOKINE-ENHANCED NK CELLS

Concept

DVX-201

Showing 1031 - 1040 of 1135 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1